China's Lepu Biotech snags $186m Series B co-led by Ping An Capital

China's Lepu Biotech snags $186m Series B co-led by Ping An Capital

Photo: Pixabay

Chinese biotech startup Lepu Biotech has raised an aggregate of 1.291 billion yuan ($186 million) in a Series B round co-led by Ping An Insurance (Group)’s investment vehicle Ping An Capital and Sunshine Insurance Group-backed private equity firm Riverhead Capital Investment Management.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter